Cray Research, Inc. announces the release of UniChem 3.0. UniChem incorporates three chemistry simulation codes with a graphical user interface (GUI). Users may run DGauss 3.0, MNDO94, or CADPAC 5.2. UniChem 3.0 also provides an optional interface to GAUSSIAN and a code attachment facility. Major new features include: - analytic second derivatives for DFT - reaction field model for both DGauss 3.0 and MNDO94 - MNDO/d parameters for 4 additional elements in MNDO94: Ti, Fe, Cu, Zr - semiempirical molecular dyanmics - a quick cleanup option in the molecular builder - the ability to perform computation and analysis on a series of structures. UniChem 3.0 runs in client/server mode, with the GUI operating on a Sun or SGI workstation and the chemistry codes on either SGI or Cray platforms. A version for the IBM RS6000 version is forthcoming. More details on UniChem 3.0 can be found in the UniChem WWW page (http://www.cray.com/apps/UNICHEM/), or by contacting unichem@cray.com. From jkromero@presto.ig.com Wed May 29 12:27 EDT 1996 Received: from presto.ig.com for jkromero@presto.ig.com by www.ccl.net (8.7.5/950822.1) id MAA03942; Wed, 29 May 1996 12:27:44 -0400 (EDT) Received: from [134.172.2.211] ([134.172.2.211]) by presto.ig.com (8.6.12/8.6.6) with SMTP id JAA04869; Wed, 29 May 1996 09:27:25 -0700 Message-Id: Mime-Version: 1.0 Date: Wed, 29 May 1996 09:31:32 -0700 To: chemistry@www.ccl.net From: jkromero@presto.ig.com (Jill Koering-Romero) Subject: Posting a press release Cc: jkromero@presto.ig.com Content-Type: text/plain; charset="us-ascii" Content-Length: 5006 Status: R Oxford Molecular Group Completes UniChem Software and Technology Acquisition from Cray Research, Inc. Agreement Strengthens Oxford Molecular's Competitiveness in Quantum Chemistry and Supports Cray's New Application Strategy CAMPBELL, Calif., May 24, 1996 - Oxford Molecular Group PLC (OMG: London Stock Exchange) and Cray Research, Inc. (NYSE: CYR) today announced that they have reached a definitive agreement for Oxford Molecular Group to acquire Cray's UniChem software package for computational chemistry applications. Under the agreement, Oxford Molecular Group purchased UniChem and a CRAY J90 supercomputer through a mixture of cash and the issue of shares to Cray. Also, Cray will become a distributor of UniChem software for Cray supercomputers. All future versions of the software will be developed by Oxford Molecular, and a comprehensive licensing and support transition plan has been developed to support current customers. The agreement includes transfer of technology and software licenses. According to Tony F. Marchington, D. Phil., chief executive officer of Oxford Molecular, the Unichem acquisition enables the company to strengthen its competitiveness in the quantum chemistry sector and adds supercomputing capabilities to the its range of software solutions for integrated molecular design. "This acquisition will complement Oxford Molecular Group's portfolio of integrated molecular design products, from gene sequencing to preclinical drug development, and continues our aggressive strategy to provide our customers with a comprehensive line of software and services to meet the needs of the multimillion-dollar drug design market," said Dr. Marchington. "We are committed to support and optimize the software for a wide range of computers, including the Cray supercomputers. Cray said the deal confirms its strategy of working primarily through independent software vendors for applications on its supercomputers. Cray officials supported the acquisition of the Unichem technology, recognizing the strong fit for the software within Oxford Molecular's future business and product development strategy. "We are happy to see our innovative UniChem technology go into the hands of a premier-quality firm like Oxford Molecular," said Mike Booth, vice president of Cray's Applications and Software Divisions. "We saw a great deal of interest from software vendors in this technology. Oxford Molecular will continue UniChem's success and broaden its use in the marketplace." UniChem is a well-established computational chemistry software package used by industry and research organizations, such as DuPont, Exxon Research & Engineering, and Phillips Petroleum, to speed the development of pharmaceuticals, materials and other chemicals. UniChem complements existing quantum mechanics solutions available from Oxford Molecular Group, giving customers greater choice in this sector. Following its realigned applications strategy last year, Cray will focus future development efforts on building unique capabilities and applications technology for its supercomputers, but discontinue its business of maintaining software like UniChem. "We have always worked closely with ISVs for mainstream applications optimized on our supercomputers," said Booth. "However, our high performance computing leadership and partnership approach with high-end industrial customers often places us in a position to develop unique applications technologies for problems that don't have solutions today. This was the case with UniChem." Cray Research, Inc., a subsidiary of Silicon Graphics, Inc., provides the leading supercomputing tools and services to help solve customers' most challenging problems. Oxford Molecular Group develops and markets solutions for integrated molecular design to companies and universities engaged in chemical, pharmaceutical and biotechnology research. In addition to a wide range of computer-aided molecular design software (CAMD), the company offers advanced bioinformatics tools as well as contract research for pharmaceutical drug discovery and design. Headquartered in Oxford, England, the company conducts U.S. operations in Campbell, Calif.; Beaverton, Ore.; Rochester, N.Y.; and Baltimore, M.D.; and European operations from Oxford; Erlangen (Germany); and Paris. Oxford Molecular Group is the largest supplier of CAMD software in Japan through its distributor Sony/Tektronix. CV.ff-5/23/96 *********************************************************************** Jill Koering-Romero Oxford Molecular Group Marketing Communications Coordinator 2105 S. Bascom Ave. jkromero@ig.com Suite 200 Tel: 408-879-6363 Campbell, CA 95008 Fax: 408-879-6302 http://www.oxmol.com/ ***********************************************************************